General Information of This Metabolic Reaction (MR) (ID: MR004918)
Formula Reactant 2-(o-carboxybenzamido)glutaric acid Product Phthalic Acid
Reactant Info Product Info
Metabolic Enzyme Nonenzymatical (Non-ME) DME Info
Metabolic Type Conjugation - Amide Hydrolyation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR014136 2-(o-carboxybenzamido)glutaramic acid 2-(o-carboxybenzamido)glutaric acid Conjugation - Amide Hydrolyation Thalidomide [1]
MR004920 2-phthalimidoglutaric acid 2-(o-carboxybenzamido)glutaric acid Conjugation - Amide Hydrolyation Thalidomide [2]
MR004916 4-(o-carboxybenzamido)glutaramic acid 2-(o-carboxybenzamido)glutaric acid Conjugation - Amide Hydrolyation Thalidomide [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR004917 2-(o-carboxybenzamido)glutaric acid Glutamic acid Conjugation - Amide Hydrolyation Thalidomide [2]
MR014138 2-(o-carboxybenzamido)glutaric acid L-Glutamine Conjugation - Amide Hydrolyation Thalidomide [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR006285 Dibutylphthalate Phthalic acid Unclear Dibutylphthalate [3]
MR004932 Alpha-(o-carboxybenzamido)glutarimide Phthalic Acid Conjugation - Amide Hydrolyation Thalidomide [2]
MR004931 2-(o-carboxybenzamido)glutaramic acid Phthalic Acid Conjugation - Amide Hydrolyation Thalidomide [2]
MR004929 4-(o-carboxybenzamido)glutaramic acid Phthalic Acid Conjugation - Amide Hydrolyation Thalidomide [2]
MR014135 Glutamic acid Phthalic Acid Conjugation - Amide Hydrolyation Thalidomide [2]
References
1 Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites
2 Thalidomide metabolism and hydrolysis: mechanisms and implications
3 PubChem:Dibutylphthalate

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.